Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Oct;54(5):570-4.
doi: 10.1016/j.toxicon.2009.01.040. Epub 2009 Apr 9.

Association of botulinum neurotoxins with synaptic vesicle protein complexes

Affiliations
Review

Association of botulinum neurotoxins with synaptic vesicle protein complexes

Michael R Baldwin et al. Toxicon. 2009 Oct.

Abstract

Botulinum neurotoxins (BoNTs) elicit flaccid paralysis by cleaving SNARE proteins within peripheral neurons. BoNTs are classified into seven serotypes, termed A-G, based on antibody cross-neutralization. Clostridia produce BoNTs as single-chain toxins that are cleaved into a di-chain protein that comprises an N-terminal zinc metalloprotease domain that is linked by a disulfide bond to the C-terminal translocation/receptor-binding domain. BoNT/A and BoNT/B utilize synaptic vesicle protein 2 (SV2) and synaptotagmin, respectively, as receptors for entry into neurons. Using affinity chromatography, BoNT/A and BoNT/B were found to bind a synaptic vesicle protein complex in CHAPS extracts of synaptic vesicles. Mass spectroscopy identified synaptic vesicle protein 2, synaptotagmin I, synaptophysin, vesicle-associated membrane protein 2, and the vacuolar ATPase-proton pump as components of the BoNT-synaptic vesicle protein complex. BoNT/A and BoNT/B possessed unique density-gradient profiles when bound to synaptic vesicle protein complexes. The identification of BoNT/A and BoNT/B bound to synaptic vesicle protein complexes provides insight into the interactions of BoNT and neuronal receptors.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Structure-function properties of the botulinum neurotoxins
(A) Ribbon diagram of BoNT/A (pdb: 3bta). (B) Linear diagram of the di-chain activated BoNT molecule consisting of a light (LC) and heavy chain (HC) bound by a single disulfide bond. HC is divided into an N-terminal translocation domain (HCT) and a C-terminal receptor binding domain (HCR).
Figure 2
Figure 2. Model for binding and entry of BoNTs at the Neuromuscular junction
BoNT/A associates with the presynaptic membrane of α-motor neurons through interactions with oligosaccharides such as ganglioside GT1b (1). Calcium influx stimulates synaptic vesicle membrane fusion (2). BoNT/A interacts with the exposed receptor complex, stimulating synaptic vesicle recycling (3). Recycled synaptic vesicles are acidified through the activity of the v-ATPase (4). Vesicle acidification drives the translocation of the BoNT/A light chain (LC/A) into the cytosol (5) completing the cycle (6).
Figure 3
Figure 3. Protocol for the identification of BoNT-HCR-binding proteins
Rat brain cortex are homogenized and subjected to differential centrifugation. Synaptic vesicles are lysed and extracted with either CHAPS or Triton-X100. A 3-FLAG epitope IP is performed to isolate HCR binding proteins. 3FLAG peptide is added to the IP to release #-FLAG-HCR form the bead along with HCR biding proteins, which are identified by MALDI-MS or Western blotting.
Figure 4
Figure 4. Model for binding of BoNTs to the synaptic vesicle protein complex
Synaptic vesicle proteins forms a large protein complex that includes synaptic vesicle protein 2 (SV2), synaptotagmin I, synaptophysin (Syp), vesicle-associated membrane protein 2 (VAMP 2) and the vacuolar proton pump (v-ATPase). The synaptic receptor complex is stable following solubilization with CHAPS and HCR/A binds to SV2 and HCR/B binds synaptotagmin I within the complex.

Similar articles

Cited by

References

    1. Baldwin MR, Barbieri JT. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry. 2007;46:3200–3210. - PubMed
    1. Belizaire R, Komanduri C, Wooten K, Chen M, Thaller C, Janz R. Characterization of synaptogyrin 3 as a new synaptic vesicle protein. J Comp Neurol. 2004;470:266–281. - PubMed
    1. Bennett MK, Calakos N, Kreiner T, Scheller RH. Synaptic vesicle membrane proteins interact to form a multimeric complex. J Cell Biol. 1992;116:761–775. - PMC - PubMed
    1. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 1993a;365:160–163. - PubMed
    1. Blasi J, Chapman ER, Yamasaki S, Binz T, Niemann H, Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. Embo J. 1993b;12:4821–4828. - PMC - PubMed

Publication types

MeSH terms